3′-Deoxy-3′-(18)F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab

With the dismal prognosis for malignant glioma patients, survival predictions become key elements in patient management. This study compares the value of 3′-deoxy-3′-(18)F-fluorothymidine ((18)F-FLT) PET and MRI for early outcome predictions in patients with recurrent malignant glioma on bevacizumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schwarzenberg, Johannes, Czernin, Johannes, Cloughesy, Timothy F., Ellingson, Benjamin M., Pope, Whitney B., Geist, Cheri, Dahlbom, Magnus, Silverman, Daniel H.S., Satyamurthy, Nagichettiar, Phelps, Michael E., Chen, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3424269/
https://ncbi.nlm.nih.gov/pubmed/22159180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.111.092387
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados